Adicet Bio, Inc. Notes Reduction
Adicet Bio, Inc. (ACET) reported Notes Reduction of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2022-05-12
- Adicet Bio, Inc. notes reduction for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Adicet Bio, Inc. notes reduction for the quarter ending 2021-03-31 was $3.98M.
| Period end | Notes Reduction 3 month |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-03-31 | $3.98M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |